Search research articles
Contact Us
Filters
Showing results (41-50 of 153) with videos related to
Page
of 16
Sort By:
International Journal of Molecular Sciences
|
June 19, 2024
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, et al.
Journal of Nanobiotechnology
|
October 11, 2023
Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
Raf Van Campenhout, Timo W M De Groof, Prashant Kadam, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 14, 2012
Site-specific labeling of his-tagged Nanobodies with ⁹⁹mTc: a practical guide
Catarina Xavier, Nick Devoogdt, Sophie Hernot, et al.
Molecular Imaging and Biology
|
September 25, 2010
Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy
Lea Olive Tchouate Gainkam, Marleen Keyaerts, Vicky Caveliers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 12, 2011
Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
Ilse Vaneycken, Nick Devoogdt, Naomi Van Gassen, et al.
Theranostics
|
November 8, 2019
Theranostics in immuno-oncology using nanobody derivatives
Quentin Lecocq, Yannick De Vlaeminck, Heleen Hanssens, et al.
International Journal of Molecular Sciences
|
November 26, 2022
Nanobodies for the Early Detection of Ovarian Cancer
Lan-Huong Tran, Geert-Jan Graulus, Cécile Vincke, et al.
Immunotherapy Advances
|
September 16, 2024
Advancements in nuclear imaging using radiolabeled nanobody tracers to support cancer immunotherapy
Katty Zeven, Yoline Lauwers, Lynn De Mey, et al.
Oncotarget
|
April 15, 2017
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers
Katrijn Broos, Marleen Keyaerts, Quentin Lecocq, et al.
Contrast Media & Molecular Imaging
|
October 12, 2010
Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
Lea Olive Tchouate Gainkam, Vicky Caveliers, Nick Devoogdt, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 153) with videos related to
Sort By:
Page
of 16
International Journal of Molecular Sciences
|
June 19, 2024
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, et al.
Journal of Nanobiotechnology
|
October 11, 2023
Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
Raf Van Campenhout, Timo W M De Groof, Prashant Kadam, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 14, 2012
Site-specific labeling of his-tagged Nanobodies with ⁹⁹mTc: a practical guide
Catarina Xavier, Nick Devoogdt, Sophie Hernot, et al.
Molecular Imaging and Biology
|
September 25, 2010
Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy
Lea Olive Tchouate Gainkam, Marleen Keyaerts, Vicky Caveliers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 12, 2011
Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
Ilse Vaneycken, Nick Devoogdt, Naomi Van Gassen, et al.
Theranostics
|
November 8, 2019
Theranostics in immuno-oncology using nanobody derivatives
Quentin Lecocq, Yannick De Vlaeminck, Heleen Hanssens, et al.
International Journal of Molecular Sciences
|
November 26, 2022
Nanobodies for the Early Detection of Ovarian Cancer
Lan-Huong Tran, Geert-Jan Graulus, Cécile Vincke, et al.
Immunotherapy Advances
|
September 16, 2024
Advancements in nuclear imaging using radiolabeled nanobody tracers to support cancer immunotherapy
Katty Zeven, Yoline Lauwers, Lynn De Mey, et al.
Oncotarget
|
April 15, 2017
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers
Katrijn Broos, Marleen Keyaerts, Quentin Lecocq, et al.
Contrast Media & Molecular Imaging
|
October 12, 2010
Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
Lea Olive Tchouate Gainkam, Vicky Caveliers, Nick Devoogdt, et al.
Page
of 16